Clinical trial
Carvedilol Versus Verapamil in Chronic Heart Failure Secondary to Non-Ischemic…
NCT00348530 · Medical University of Silesia, Other · Unknown status
Key facts
| NCT number | NCT00348530 |
|---|---|
| Title | Carvedilol Versus Verapamil in Chronic Heart Failure Secondary to Non-Ischemic Cardiomyopathy |
| Official title | Prospective, Randomized Comparison of Therapy With Verapamil or Carvedilol on Long-Term Outcomes of Patients With Chronic Heart Failure Secondary to Non-Ischemic Cardiomyopathy |
| Lead sponsor | Medical University of Silesia, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Systolic Heart Failure, Myocardial Disease, Cardiomyopathy |
| Intervention type | Drug |
| Interventions | Verapamil |
| Enrollment | 120 |
| Start date | Jan 1, 2006 |
| Completion | Dec 1, 2007 |
| First posted | Jul 4, 2006 |
| Last update posted | Oct 18, 2006 |
| Countries | Poland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: